Techno Drugs Ltd. (DSE:TECHNODRUG)

Techno Drugs Statistics

Total Valuation

Techno Drugs has a market cap or net worth of BDT 4.18 billion. The enterprise value is 6.56 billion.

Market Cap	4.18B
Enterprise Value	6.56B

Important Dates

The last earnings date was Thursday, January 29, 2026.

Earnings Date	Jan 29, 2026
Ex-Dividend Date	Nov 20, 2025

Share Statistics

Techno Drugs has 132.00 million shares outstanding. The number of shares has increased by 30.38% in one year.

Current Share Class	132.00M
Shares Outstanding	132.00M
Shares Change (YoY)	+30.38%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	62.72%
Owned by Institutions (%)	n/a
Float	49.21M

Valuation Ratios

The trailing PE ratio is 20.36.

PE Ratio	20.36
Forward PE	n/a
PS Ratio	1.33
PB Ratio	1.02
P/TBV Ratio	1.02
P/FCF Ratio	n/a
P/OCF Ratio	13.47
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.06, with an EV/FCF ratio of -46.21.

EV / Earnings	31.92
EV / Sales	2.08
EV / EBITDA	6.06
EV / EBIT	9.58
EV / FCF	-46.21

Financial Position

The company has a current ratio of 4.05, with a Debt / Equity ratio of 0.67.

Current Ratio	4.05
Quick Ratio	1.91
Debt / Equity	0.67
Debt / EBITDA	2.53
Debt / FCF	-19.30
Interest Coverage	1.62

Financial Efficiency

Return on equity (ROE) is 5.11% and return on invested capital (ROIC) is 8.77%.

Return on Equity (ROE)	5.11%
Return on Assets (ROA)	5.78%
Return on Invested Capital (ROIC)	8.77%
Return on Capital Employed (ROCE)	10.19%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	2.19M
Profits Per Employee	142,931
Employee Count	1,438
Asset Turnover	0.43
Inventory Turnover	1.81

Taxes

In the past 12 months, Techno Drugs has paid 56.26 million in taxes.

Income Tax	56.26M
Effective Tax Rate	21.49%

Stock Price Statistics

The stock price has decreased by -7.31% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-7.31%
50-Day Moving Average	30.18
200-Day Moving Average	31.20
Relative Strength Index (RSI)	57.21
Average Volume (20 Days)	985,870

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Techno Drugs had revenue of BDT 3.15 billion and earned 205.53 million in profits. Earnings per share was 1.56.

Revenue	3.15B
Gross Profit	1.36B
Operating Income	684.90M
Pretax Income	261.80M
Net Income	205.53M
EBITDA	1.05B
EBIT	684.90M
Earnings Per Share (EPS)	1.56

Balance Sheet

The company has 364.37 million in cash and 2.74 billion in debt, with a net cash position of -2.38 billion or -18.00 per share.

Cash & Cash Equivalents	364.37M
Total Debt	2.74B
Net Cash	-2.38B
Net Cash Per Share	-18.00
Equity (Book Value)	4.10B
Book Value Per Share	31.08
Working Capital	2.58B

Cash Flow

In the last 12 months, operating cash flow was 310.68 million and capital expenditures -452.64 million, giving a free cash flow of -141.96 million.

Operating Cash Flow	310.68M
Capital Expenditures	-452.64M
Free Cash Flow	-141.96M
FCF Per Share	-1.08

Margins

Gross margin is 43.30%, with operating and profit margins of 21.74% and 6.53%.

Gross Margin	43.30%
Operating Margin	21.74%
Pretax Margin	8.31%
Profit Margin	6.53%
EBITDA Margin	33.48%
EBIT Margin	21.74%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 3.15%.

Dividend Per Share	1.00
Dividend Yield	3.15%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	21.99%
Buyback Yield	-30.38%
Shareholder Yield	-27.23%
Earnings Yield	4.91%
FCF Yield	-3.39%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Techno Drugs has an Altman Z-Score of 2.16 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.16
Piotroski F-Score	6